- Home
- IBRX vs PCTY Comparison
IBRX vs PCTY Comparison
Compare IBRX & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | PCTY |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.8B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IBRX | PCTY |
|---|---|---|
| Price | $8.46 | $144.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 17 |
| Target Price | $12.57 | ★ $176.59 |
| AVG Volume (30 Days) | ★ 8.4M | 471.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | 22.39 |
| EPS | N/A | ★ 4.92 |
| Revenue | $113,288,000.00 | ★ $1,771,326,000.00 |
| Revenue This Year | $88.59 | $11.52 |
| Revenue Next Year | $131.15 | $7.98 |
| P/E Ratio | ★ N/A | $29.72 |
| Revenue Growth | ★ 668.31 | 11.04 |
| 52 Week Low | $1.95 | $92.99 |
| 52 Week High | $12.43 | $169.09 |
Technical Indicators
Market Signals| Indicator | IBRX | PCTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.26 | 45.76 |
| Support Level | $6.68 | $140.01 |
| Resistance Level | $8.51 | $155.07 |
| Average True Range (ATR) | 0.40 | 4.34 |
| MACD | 0.02 | -1.42 |
| Stochastic Oscillator | 68.10 | 17.34 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About PCTY Paylocity Holding Corporation
Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.